ArticleMayo Clinic proceedings. Innovations, quality & outcomes2026
Patterns of Glaucoma Treatment Use in Asian American Patients With Primary Open-Angle Glaucoma.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize racial disparities in glaucoma management by evaluating treatment modality utilization patterns between Asian American and non-Asian American patients with primary open-angle glaucoma (POAG). Patients and Methods: This retrospective cohort study utilized the TriNetX US Collaborative Network, a large-scale, multi-institutional electronic medical record database, with data from January 1, 2004, to June 16, 2025. Asian American and non-Asian American patients with POAG were identified via ICD-10 codes and stratified by disease severity (mild-to-moderate vs severe). Cohorts were balanced using 1:1 propensity score matching for demographic characteristics, systemic comorbidities, family history, and smoking status. The primary outcome was the relative utilization of topical medications, laser procedures, traditional surgery, and microinvasive glaucoma surgery. Results: After propensity score matching, the study evaluated 12,526 patients with mild-to-moderate POAG (6263 per group) and 3410 patients with severe POAG (1705 per group). In the mild-to-moderate cohort, Asian Americans had a higher likelihood of receiving topical medications (odds ratio [OR], 1.041; 95% confidence interval [CI], 1.016-1.068). Conversely, Asian Americans with severe POAG were less likely to receive topical medications (OR, 0.950; 95% CI, 0.906-0.996) or laser procedures (OR, 0.769; 95% CI, 0.630-0.939). No significant differences were observed in surgical or microinvasive glaucoma surgery utilization. Conclusion: Significant differences exist in POAG treatment utilization for Asian Americans, particularly a relative underutilization of adjunctive medical and laser therapies in severe disease. These findings suggest that current practice patterns may diverge from traditional treatment algorithms for this rapidly growing demographic, highlighting a need for increased awareness of potential systemic or provider-level barriers to equitable care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.